BIO-TECHNE CORP. DL-,01BIO-TECHNE CORP. DL-,01BIO-TECHNE CORP. DL-,01

BIO-TECHNE CORP. DL-,01

No trades
See on Supercharts
Next report date
Report period
Q4 2024
EPS estimate
0.46EUR
Revenue estimate
‪286.11 M‬EUR
Market capitalization
‪10.78 B‬EUR
‪261.47 M‬EUR
‪1.04 B‬EUR
‪155.57 M‬
Beta (1Y)
1.24

About Bio-Techne Corp

CEO
Kim Kelderman
Headquarters
Minneapolis
Employees (FY)
‪3.05 K‬
Founded
1976
FIGI
BBG000GN3CZ3
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where TE1 is featured.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIO-TECHNE CORP. DL-,01 stocks are traded under the ticker TE1.
BIO-TECHNE CORP. DL-,01 is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
TE1 earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.37 EUR resulting in a −2.95% surprise. The estimated earnings for the next quarter are 0.42 EUR per share. See more details about BIO-TECHNE CORP. DL-,01 earnings.
BIO-TECHNE CORP. DL-,01 revenue for the last quarter amounts to ‪246.98 M‬ EUR despite the estimated figure of ‪251.46 M‬ EUR. In the next quarter revenue is expected to reach ‪270.95 M‬ EUR.
Yes, you can track BIO-TECHNE CORP. DL-,01 financials in yearly and quarterly reports right on TradingView.
TE1 net income for the last quarter is ‪45.47 M‬ EUR, while the quarter before that showed ‪24.88 M‬ EUR of net income which accounts for 82.74% change. Track more BIO-TECHNE CORP. DL-,01 financial stats to get the full picture.
Yes, TE1 dividends are paid quarterly. The last dividend per share was 0.07 EUR. As of today, Dividend Yield (TTM)% is 0.42%. Tracking BIO-TECHNE CORP. DL-,01 dividends might help you take more informed decisions.
BIO-TECHNE CORP. DL-,01 dividend yield was 0.39% in 2023, and payout ratio reached 18.16%. The year before the numbers were 0.37% and 19.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, TE1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-TECHNE CORP. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
TE1 reached its all-time high on Sep 21, 2021 with the price of 115.0 EUR, and its all-time low was 4.5 EUR and was reached on Apr 10, 2003. View more price dynamics on TE1 chart.
See other stocks reaching their highest and lowest prices.
As of May 3, 2024, the company has ‪3.05 K‬ employees. See our rating of the largest employees — is BIO-TECHNE CORP. DL-,01 on this list?
We've gathered analysts' opinions on BIO-TECHNE CORP. DL-,01 future price: according to them, TE1 price has a max estimate of 88.66 EUR and a min estimate of 60.66 EUR. Watch TE1 chart and read a more detailed BIO-TECHNE CORP. DL-,01 stock forecast: see what analysts think of BIO-TECHNE CORP. DL-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-TECHNE CORP. DL-,01 EBITDA is ‪332.31 M‬ EUR, and current EBITDA margin is 34.13%. See more stats in BIO-TECHNE CORP. DL-,01 financial statements.